Literature DB >> 30100074

Overview of Breast Cancer Therapy.

Tracy-Ann Moo1, Rachel Sanford2, Chau Dang2, Monica Morrow3.   

Abstract

Breast cancer treatment is multidisciplinary. Most women with early stage breast cancer are candidates for breast-conserving surgery with radiotherapy or mastectomy. The risk of local recurrence and the chance of survival does not differ with these approaches. Sentinel node biopsy is used for axillary staging, and individualized approaches are minimizing the need for axillary dissection in women with positive sentinel nodes. Adjuvant systemic therapy is used in most women based on proven survival benefit, and molecular profiling to individualize treatment based on risk is now a clinical reality for patients with hormone receptor-positive cancers.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjuvant therapy; Breast cancer surveillance; Breast cancer therapy; Breast-conserving therapy; Endocrine therapy; Local therapy; Mastectomy; Neoadjuvant chemotherapy

Mesh:

Year:  2018        PMID: 30100074      PMCID: PMC6092031          DOI: 10.1016/j.cpet.2018.02.006

Source DB:  PubMed          Journal:  PET Clin        ISSN: 1556-8598


  122 in total

1.  Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.

Authors:  Y Xing; M Foy; D D Cox; H M Kuerer; K K Hunt; J N Cormier
Journal:  Br J Surg       Date:  2006-05       Impact factor: 6.939

2.  [Axillary lymph node dissection versus axillary radiotherapy in patients with a positive sentinel node: the AMAROS trial].

Authors:  Mila Donker; Leen Slaets; Geertjan van Tienhoven; Emiel J Th Rutgers
Journal:  Ned Tijdschr Geneeskd       Date:  2015

3.  Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.

Authors:  K A Kern
Journal:  J Am Coll Surg       Date:  1999-12       Impact factor: 6.113

4.  An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence.

Authors:  Nehmat Houssami; Robin Turner; Petra Macaskill; Lindsay W Turnbull; David R McCready; Todd M Tuttle; Neha Vapiwala; Lawrence J Solin
Journal:  J Clin Oncol       Date:  2014-01-06       Impact factor: 44.544

5.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Authors:  M Overgaard; M B Jensen; J Overgaard; P S Hansen; C Rose; M Andersson; C Kamby; M Kjaer; C C Gadeberg; B B Rasmussen; M Blichert-Toft; H T Mouridsen
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

6.  Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?

Authors:  Maxine S Jochelson; Katharine Lampen-Sachar; Girard Gibbons; Chau Dang; Diana Lake; Elizabeth A Morris; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2015-03-17       Impact factor: 5.344

7.  Usefulness of magnetic resonance in patients with invasive cancer eligible for breast conservation: a comparative study.

Authors:  Alessandro Fancellu; Daniela Soro; Paolo Castiglia; Vincenzo Marras; Marcovalerio Melis; Pietrina Cottu; Alessandra Cherchi; Angela Spanu; Silvia Mulas; Claudio Pusceddu; Luca Simbula; Giovanni B Meloni
Journal:  Clin Breast Cancer       Date:  2013-10-25       Impact factor: 3.225

8.  Late results of skin-sparing mastectomy followed by immediate breast reconstruction.

Authors:  T J Meretoja; S Rasia; K A J von Smitten; S L Asko-Seljavaara; H O M Kuokkanen; T A Jahkola
Journal:  Br J Surg       Date:  2007-10       Impact factor: 6.939

9.  Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.

Authors:  Armando E Giuliano; Karla V Ballman; Linda McCall; Peter D Beitsch; Meghan B Brennan; Pond R Kelemen; David W Ollila; Nora M Hansen; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Monica Morrow
Journal:  JAMA       Date:  2017-09-12       Impact factor: 56.272

10.  Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.

Authors:  Sandra M Swain; Gong Tang; Charles E Geyer; Priya Rastogi; James N Atkins; Paul P Donnellan; Louis Fehrenbacher; Catherine A Azar; André Robidoux; Jonathan A Polikoff; Adam M Brufsky; David D Biggs; Edward A Levine; John L Zapas; Louise Provencher; Donald W Northfelt; Soonmyung Paik; Joseph P Costantino; Eleftherios P Mamounas; Norman Wolmark
Journal:  J Clin Oncol       Date:  2013-08-12       Impact factor: 44.544

View more
  63 in total

1.  Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug Products.

Authors:  Andrea Allmendinger
Journal:  Pharm Res       Date:  2021-04-26       Impact factor: 4.200

2.  Racial Differences in Response to Neoadjuvant Chemotherapy: Impact on Breast and Axillary Surgical Management.

Authors:  Theresa Relation; Samilia Obeng-Gyasi; Oindrila Bhattacharyya; Yaming Li; Mariam F Eskander; Allan Tsung; Bridget A Oppong
Journal:  Ann Surg Oncol       Date:  2021-02-14       Impact factor: 5.344

3.  Stress-induced phosphoprotein 1 facilitates breast cancer cell progression and indicates poor prognosis for breast cancer patients.

Authors:  Lizhi Lin; Jialiang Wen; Bangyi Lin; Erjie Xia; Chen Zheng; Lechi Ye; Yinghao Wang; Ouchen Wang; Yizuo Chen
Journal:  Hum Cell       Date:  2021-03-04       Impact factor: 4.174

4.  Phrenic Nerve Palsy Following Radiation Therapy for Patient With Breast Cancer.

Authors:  Akhil Sharma; Fazal Raziq; Tyler Kemnic; Rohan Prasad
Journal:  Perm J       Date:  2021-12-10

Review 5.  Goldilocks Procedure without a Vertical Incision and a Comprehensive Literature Review.

Authors:  Hilton Becker; Oscar Adrian Vazquez; Jacob Komberg
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-08-23

Review 6.  Experiences of women with breast cancer while working or returning to work: a qualitative systematic review and meta-synthesis.

Authors:  Faustine Sze Ing Tan; Shefaly Shorey
Journal:  Support Care Cancer       Date:  2021-10-13       Impact factor: 3.603

7.  Lidocaine enhances the efficacy of palbociclib in triple-negative breast cancer.

Authors:  Beom Seok Han; Kyung Hee Jung; Ji Eun Lee; Young-Chan Yoon; Soyeon Ko; Min Seok Park; Yun Ji Lee; Sang Eun Kim; Ye Jin Cho; Pureunchowon Lee; Joo Han Lim; Eunsoo Jang; Hyunzu Kim; Soon-Sun Hong
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

8.  Targeted Proteomic Analysis Revealed Kinome Reprogramming during Acquisition of Radioresistance in Breast Cancer Cells.

Authors:  Weili Miao; David Bade; Yinsheng Wang
Journal:  J Proteome Res       Date:  2021-03-19       Impact factor: 4.466

Review 9.  Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer.

Authors:  Tyrillshall S T Damiana; Simone U Dalm
Journal:  Pharmaceutics       Date:  2021-05-07       Impact factor: 6.321

10.  Cytotoxic T cells response with decreased CD4/CD8 ratio during mammary tumors inhibition in rats induced by non-contact electric fields.

Authors:  Firman Alamsyah; Rarastoeti Pratiwi; Nisrina Firdausi; Jessica Irene Mesak Pello; Subekti Evi Dwi Nugraheni; Ahmad Ghitha Fadhlurrahman; Luthfi Nurhidayat; Warsito Purwo Taruno
Journal:  F1000Res       Date:  2021-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.